GenePath Dx Overview
- Year Founded
-
2008

- Status
-
Private
- Employees
-
75

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$336K
- Investors
-
3
GenePath Dx General Information
Description
Operator of a molecular diagnostics company intended to screen and diagnose diseases. The company offers state-of-the-art in vitro diagnostic assays, test kits and techniques, including molecular diagnostics, for infectious diseases, cancers, and genetic disorders, enabling medical, healthcare and allied communities to get accurate, reliable, rapid, and affordable diagnostics results.
Contact Information
Website
www.genepathdx.comCorporate Office
- 1260/B Jangli Maharaj Road, Plot 596
- Above Phadke Hospital, across from McDonald Deccan Gymkhana, Shivajinagar
- Pune, Maharashtra 411016
- India
Corporate Office
- 1260/B Jangli Maharaj Road, Plot 596
- Above Phadke Hospital, across from McDonald Deccan Gymkhana, Shivajinagar
- Pune, Maharashtra 411016
- India
GenePath Dx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Grant | 23-Nov-2020 | $336K | Completed | Generating Revenue | ||
4. Later Stage VC | 05-Jul-2017 | Completed | Generating Revenue | |||
3. Later Stage VC | 01-Feb-2016 | Completed | Generating Revenue | |||
2. Later Stage VC | 11-Feb-2015 | $403K | $1.06M | Completed | Generating Revenue | |
1. Later Stage VC | 28-Aug-2014 | $658K | $658K | Completed | Generating Revenue |
GenePath Dx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary |
GenePath Dx Patents
GenePath Dx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4034671-A1 | Composition and method for improving detection of biomolecules in biofluid samples | Pending | 24-Sep-2019 | ||
US-20220396824-A1 | Composition and method for improving detection of biomolecules in biofluid samples | Pending | 24-Sep-2019 | ||
EP-4034671-A4 | Composition and method for improving detection of biomolecules in biofluid samples | Pending | 24-Sep-2019 | ||
US-20220195502-A1 | Method for detecting specific nucleic acids in samples | Pending | 24-Apr-2019 | ||
EP-3959337-A1 | Method for detecting specific nucleic acids in samples | Pending | 24-Apr-2019 | C12Q1/6827 |
GenePath Dx Signals
GenePath Dx Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
US India Science and Technology Endowment Fund | Limited Partner | |||
Saama Capital | Venture Capital | Minority | ||
Snow Leopard Ventures | Corporate Venture Capital | Minority |
GenePath Dx FAQs
-
When was GenePath Dx founded?
GenePath Dx was founded in 2008.
-
Where is GenePath Dx headquartered?
GenePath Dx is headquartered in Pune, India.
-
What is the size of GenePath Dx?
GenePath Dx has 75 total employees.
-
What industry is GenePath Dx in?
GenePath Dx’s primary industry is Diagnostic Equipment.
-
Is GenePath Dx a private or public company?
GenePath Dx is a Private company.
-
What is GenePath Dx’s current revenue?
The current revenue for GenePath Dx is
. -
How much funding has GenePath Dx raised over time?
GenePath Dx has raised $1.36M.
-
Who are GenePath Dx’s investors?
US India Science and Technology Endowment Fund, Saama Capital, and Snow Leopard Ventures have invested in GenePath Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »